

Pharmaceutical companies have been ordered to make sure the quality and efficacy of their drugs are on par with brand-name drugs, a move that aims to improve the nation's pharma industry.
According to a circular issued by the State Council General Office, generic drugs already available on the market should be assessed on whether they are consistent with brand-name drugs, and if they could be used clinically.
The assessment should be in-house, and the drug watchdog will publicize those medicines that passed the assessment, the circular said.
The government will also include drugs in the nation insurance program if they pass the assessment and public hospitals will prioritize these drugs in procurement, among other favorable policies.
Bi Jingquan, head of the China Food and Drug Administration, said the assessment will be a challenge for firms, but it is necessary if China wants to become a pharmaceutical power.
Generic drugs, intended as interchangeable products, are often as effective as, but much cheaper than, brand-name drugs, according to the World Health Organization definition.
China has world's largest high-speed rail network
Top beauties in Chinese provinces
600 people attend Lusheng playing contest in S China
Engineer troop builds bridge in real combat conditions
You can urinate in public in Chongqing
Rice terrace scenery in southwest China's Yunnan
2016 Miss Chinatown USA pageant held in San Francisco
Ancient pagodas across China
Wedding dress show up in the air
Top 20 hottest women in the world in 2014
Top 10 hardest languages to learn
10 Chinese female stars with most beautiful faces
China’s Top 10 Unique Bridges, Highways and Roads
Harris is making waves in S.China Sea
With new plant, Airbus seeks to secure China market share
Chinese sound off on America’s loudest presidential hopeful
40 years after Cultural Revolution, repentance of Red Guards is still rareDay|Week